Health Media ArticlesExcerpts of Key Health Media Articles in Major Media
Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.
For further exploration, delve into our comprehensive Health and Food Corruption Information Center.
Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
The new movie Consumed tackles the controversial world of Genetically Modified Organisms (GMOs) in unprecedented fashion, offering insight into their risks. Its message could not be more timely in the wake of the recent news that the Food and Drug Administration has approved the first genetically engineered salmon for human consumption. The fish, like all genetically engineered ingredients in this country, will not be labeled, leaving American consumers in the dark. Like many food and environmental safety activists around the world, I’m outraged. The biotech industry and the FDA have hijacked not only our basic rights as consumers, but also our fundamental human rights in the face of corporate monopolization of our food supply. They are jeopardizing our health and the environment more than ever before. In detailed comments submitted to the FDA, Michael Hansen, senior scientist at Consumers Union, argues the FDA review process was based on “sloppy science” and the genetically engineered salmon could pose many risks. “Because FDA’s assessment is inadequate, we are particularly concerned that this salmon may pose an increased risk of severe, even life-threatening allergic reactions,” he writes. The majority of Americans ... believe they have a fundamental right to know what is in their food. A 2013 New York Times poll found that 93% of Americans want GMOs to be labeled. More than 60 countries label GMOs, and in some cases even ban them, but the U.S. still does not.
Note: Read an excellent mercola.com article titled "GMO cookie is crumbling." For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.
In approving genetically engineered salmon as safe to eat and safe for the environment, the Food and Drug Administration rejected petitions from environmental and food safety groups asking that companies selling this salmon be required to label it as genetically engineered. Congress should overturn that decision. The salmon, made by AquaBounty Technologies of Maynard, Mass., has genes inserted that allow it to grow to market size twice as fast as wild salmon. At least one consumer group has announced plans to sue the F.D.A. to overturn its approval of the engineered salmon. Some leading grocery chains, responding to consumer concerns, have said they won’t sell the genetically engineered salmon. The F.D.A. said there is no reason to mandate labeling because there is no material difference between engineered and natural fish. But the value of that information should be left to consumers to decide. Vermont enacted a law last year that will require labeling of genetically engineered foods starting next July unless a suit filed in June 2014 by four industry trade groups derails it. Other states with strong consumer movements may try to follow. The House passed a bill on July 23, 2015, that would pre-empt states from requiring such labeling, and industry groups are pressing the Senate to attach similar language as a rider to an omnibus spending bill. The Senate should rebuff that tactic and allow states to adopt mandatory labeling laws if they wish.
Note: For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.
Dow AgroSciences, which sells seeds and pesticides to farmers, made contradictory claims to different parts of the U.S. government about its latest herbicide. The Environmental Protection Agency just found out, and now wants to cancel Dow's legal right to sell the product. The herbicide, which the company calls Enlist Duo, is a mixture of two chemicals: glyphosate (also known as Roundup) and 2,4-D. It's Dow's answer to the growing problem of weeds that are resistant to glyphosate, which has become the weed-killing weapon of choice for farmers across the country. The new formulation is intended to work hand-in-hand with a new generation of corn and soybean seeds that are genetically engineered to tolerate sprays of both herbicides. When Dow applied for permission to sell Enlist Duo in 2011, it told the EPA that this mixture of glyphosate and 2,4-D is no more toxic than the two chemicals are, if considered separately. The EPA ... approved the new herbicide just over a year ago, [yet later] discovered that Dow had been telling the U.S. Patent and Trademark Office a different story. Dow's patent application for Enlist Duo claims that this mixture of chemicals does, in fact, offer farmers something new: "synergistic herbicidal weed control." Last month, the EPA asked Dow to explain these synergistic effects. On Nov. 9, the company responded with what the EPA calls "extensive information." The EPA, after taking a look at the new information, decided to ask the court for a chance to reverse its approval of Enlist Duo.
Note: Read an excellent mercola.com article titled "GMO cookie is crumbling." For more along these lines, see concise summaries of deeply revealing news articles about the corruption of science and the controversy surrounding GMOs.
The world’s biggest animal “cloning factory” is due to open in China, producing one million calves a year, sniffer dogs and even genetic copies of the family pet. The center may cause alarm in Europe, where the cloning of animals for farming was banned in September due to animal welfare considerations. But Xu Xiaochun, chairman of Chinese biotechnology company BoyaLife that is backing the facility, dismissed such concerns. Interest in agricultural biotechnology has been rapidly increasing in China, where [beef prices] are said to have tripled from 2000 to 2013. Mr Xu said his new facility will clone racehorses and a handful of dogs for people with “emotional ties” to their pets, but its main focus was producing cattle. However, he appeared to be more excited about its ability to churn out sniffer dogs. “The dog has to be smart and obedient, strong, sensitive," he said. The factory, which will include a 15,000 square metre laboratory, an animal centre, a gene bank and an exhibition hall ... is due to open in the first half of next year. BoyaLife will operate the facility with its South Korean partner, Sooam Biotech, that runs a centre that can clone dogs for customers willing to pay $100,000 (Ł66,000), and has already produced more than 550 puppies. The new facility will initially produce 100,000 cattle embryos a year, eventually increasing to one million.
Note: For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.
Consumer advocates, environmental groups, fishermen and retailers reacted strongly to the federal government’s announcement Thursday approving genetically modified salmon for consumer use. The landmark approval - the first genetically engineered food animal endorsed for sale in the United States - has sparked a passionate response ... especially because it will not require special labelling. Around 2 million people previously filed public comments against the FDA’s approval of what opponents call “Frankenfish,” and the Center for Food Safety announced Thursday that it would sue the FDA in response. “This sets the bar incredibly low for engineered animals,” said Michael Hansen, senior scientist at Consumers Union. “There were serious problems with the safety assessment.” At least 60 retailers - including chains like Safeway, Target, Whole Foods and Trader Joe’s, as well as local independent grocers like Bi-Rite and Rainbow Community Market - have made a pledge with Friends of the Earth not to sell the salmon when it goes to market. Chief among concerns about the GMO salmon is its potential for causing allergies and its ability to contaminate wild populations. Testing for potential allergens was only done on a very small sample size. The tested fish actually did show a higher allergenicity. Critics are also concerned about the fish’s ability to escape and cause environmental harm.
Note: For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.
Americans may not agree on much. But according to polls, more than 90 percent support genetically engineered (GE) food labeling. Despite the industrial food complex spending hundreds of millions on lobbying against labeling, three states have responded to the call from their voters and passed labeling laws. Vermont's laws will require that companies start labeling by July, 2016. This deadline has the agribusiness community scrambling for a way out. The biotech industry, along with its top enabler at the U.S. Department of Agriculture, Secretary Tom Vilsack, is trying to sell the idea that the long derided and poorly utilized QR code is the answer to consumer concerns about GE foods. A QR code ... is similar to a bar code. To use it, a person must have a smartphone device, an internet connection, and a QR code reader downloaded onto his or her phone. Vilsack and now even Presidential nominee Hillary Clinton are promoting QR code information on GE foods as sufficient to rescind the mandatory on package clear and accessible labeling required by the state laws. Substituting clear and accessible on-package labeling with QR codes would be a form of discrimination against the poor, the rural, the elderly and many other groups. We do not want this discriminatory, burdensome and privacy invasive technology to become the norm.
Note: Read more about why the overwhelming majority of Americans believe GMO foods should require labels. For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.
The American Medical Association on Tuesday called for a ban on direct-to-consumer ads for prescription drugs and implantable medical devices, saying they contribute to rising costs and patients' demands for inappropriate treatment. Delegates at the influential group's policy-making meeting in Atlanta voted to adopt that as official policy as part of an AMA effort to make prescription drugs more affordable. It means AMA will lobby for a ban. "Today's vote in support of an advertising ban reflects concerns among physicians about the negative impact of commercially driven promotions and the role that marketing costs play in fueling escalating drug prices," said Dr. Patrice Harris, an AMA board member. According to data cited in an AMA news release, ad dollars spent by drugmakers have risen to $4.5 billion in the last two years, a 30 percent increase. Other data show prices on prescription drugs have climbed nearly 5 percent this year, Harris said in the news release. She also raised concern that advertising spurs use of newer brand-name drugs when other possibly lower-cost options might be just as good. "Direct-to-consumer advertising also inflates demand for new and more expensive drugs, even when these drugs may not be appropriate." The pharmaceutical industry opposes the AMA's stance.
Note: For more along these lines, see concise summaries of deeply revealing big pharma profiteering news articles from reliable major media sources. Then read an in-depth essay titled "The Truth About Drug Companies" by acclaimed author Dr. Marcia Angell.
This season’s flu vaccine is not as effective against the virus as had been previously believed. Health experts had high hopes for this year’s vaccine because of changes to the recipe following last season’s disappointing success rate. Creating the flu vaccine is not an exact science. Health officials from around the world make their best guesses as to what flu strains to prepare for. They must make their recommendations months in advance so vaccine makers will have time to create and distribute the serum. So far this year, the vaccine has been found to be just 18 percent effective for adults against the H3N2 strain, the dominant strain this season. Officials had hoped for 50 to 60 percent effectiveness for this season’s batch.
Note: According to this NPR article, last year "the vaccine was only about 13 percent effective against the main strain." Could it be that we are being tricked into believing these vaccines a much more effective than they really are? For more, see this mercola.com article. For more along these lines, see concise summaries of deeply revealing vaccine controversy news articles from reliable major media sources.
A potential anti-Alzheimer’s drug tested in mice unexpectedly reduced general symptoms of aging, according to a study led by Salk Institute researchers. The study examined the effects of the drug, J147, in a strain of mice bred to rapidly age and show signs of senescence. It is the second mouse model to show effectiveness. Besides improved cognition compared to controls, the treated mice exhibited better metabolism, reduced blood leakage from microvessels in the brain, and other improvements. Researchers ... published the study Wednesday in the journal Aging. Abrexa Pharmaceuticals, a San Diego company formed to commercialize J147, has licensed the compound from Salk. The drug is to be tested for Alzheimer's, not for anti-aging properties. Derived from a spice in curry, [J147] was developed ... based on the observation that people in India, where curry is widely consumed, rarely get Alzheimer's. The potential drug has been previously tested in Alzheimer's model mice. It was found to have memory-enhancing effects. The new study, showing effectiveness in another strain of mice, lends further credence to J147's usefulness.
Note: For more on J147 see this article in U.S. News & World Report (particularly the video at the bottom of the page) or do a search on J177. Some are claiming that big Pharma won't study this promising drug as it won't make big enough profits for them.
The Environmental Protection Agency concluded in June that there was “no convincing evidence” that glyphosate, the most widely used herbicide in the U.S. and the world, is an endocrine disruptor. The decision was based almost entirely on pesticide industry studies. Most of the studies were sponsored by Monsanto or an industry group called the Joint Glyphosate Task Force. Of the small minority of independently funded studies that the agency considered in determining whether the chemical poses a danger to the endocrine system, three of five found that it did. One, for instance, found that exposure to glyphosate-Roundup “may induce significant adverse effects on the reproductive system of male Wistar rats.” Another concluded that “low and environmentally relevant concentrations of glyphosate possessed estrogenic activity.” And a review of the literature turns up many more peer-reviewed studies finding glyphosate can interfere with hormones. Many of the industry-funded studies contained data that suggested that exposure to glyphosate had serious effects. Yet in each case, sometimes even after animals died, the scientists found reasons to discount the findings — or to simply dismiss them. Having companies fund and perform studies that affect them financially [is] the standard practice at EPA. The International Agency for Research on Cancer labeled glyphosate a probable carcinogen in March.
Note: Read an excellent mercola.com article titled "GMO cookie is crumbling." Monsanto is trying to stop the state of California from listing Glyphosate as carcinogenic. For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.
Two kinds of genetically modified pigs are on their way to becoming ... dinner. But consumers are wary and lack confidence in governments' readiness to regulate this new class of food product. The African swine fever resistant pig has an immune gene that is slightly more like a warthog's. The double-muscle pig has a mutation similar to one produced by normal breeding in a muscly cow breed called the Belgian blue. Lucy Sharratt, co-ordinator for the Canadian Biotechnology Network, said a major reason why consumers are wary is because of the way genetically modified foods are regulated in Canada. Health Canada doesn't do its own testing of the foods, relying instead on data generated by the companies trying to put the foods on the market, which is kept secret. It doesn't disclose what it's assessing. Nor does it consult with farmers or consumers, or require labelling of genetically modified foods after the fact. In the U.S., safety information about genetically modified foods is also kept secret.
Note: For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.
Over 100 protesters gathered outside of the Centers for Disease Control offices in Atlanta demanding transparency when it comes to vaccines. [They] say that the information being provided to the public about vaccines isn’t honest. On August 27, 2014 [CDC scientist Dr. William Thompson] made an admission that got very little media coverage. But it was a major statement. That statement read in part, “I regret that my co-authors and I omitted statistically significant information in our 2004 article published in the journal Pediatrics. “The omitted data suggested that African American males who received the MMR (mumps, measles and rubella) vaccine before age 36 months were at increased risk for autism. Decisions were made regarding the findings ... and I believe that the final study protocol was not followed.” Thompson ... hired a whistleblower attorney and turned over documents to Congress. As many as 100,000 documents were turned over. Congressman [Bill] Posey brought this information to the floor of Congress and what he read there was stunning - that authors of the study not only hid the actual findings, but also attempted to destroy evidence [by throwing it] into a trash can. What you might not know is that all vaccines in all quantities for all people are not safe. Every year hundreds of children are injured by vaccines, and since 1986 the United States Government has paid out $3 billion to the vaccine injury compensation program. Raise even one question about why that is, and you’ll get pushback.
Note: Strangely, CBS 46 in Atlanta appears to have removed this from their website. You can see a video of the CBS broadcast at this link. Read further commentary on this important topic in an article by Robert F. Kennedy, Jr. For more along these lines, see concise summaries of deeply revealing vaccine controversy news articles from reliable major media sources.
Turing Pharmaceuticals chief executive Martin Shkreli found himself in the middle of a media firestorm last month as he adamantly defended his company's 4,000 percent drug price hike. Daraprim, which treats a life-threatening infection in patients with HIV/AIDS and other immune problems, was increased to $750 a pill, a move resoundingly decried. Now, another company will offer a Daraprim alternative, at just $1 a pill. It's not an exact replica of Daraprim. San Diego-based Imprimis Pharmaceuticals announced Thursday that it is selling pills containing a "customizable compounded formulation" of pyrimethamine and leucovorin, both ingredients in Daraprim. The Food and Drug Administration doesn't approve compounded drugs, such as this one offered by Imprimis. Typically, compounded drugs are prescribed to patients who can't take FDA-approved drugs, such as for those who are allergic to an inactive ingredient. Compounded drugs are no stranger to controversy; a compounding pharmacy was at the heart of a deadly meningitis outbreak in 2012 that killed 64 people and sickened more than 600. Federal legislators subsequently tightened regulations over such companies. And compounded drugs can be very pricey, too. But it appears the Daraprim alternative compound was not born out of a physical inability to use Daraprim, but a financial one.
Note: Read more about Turing Pharmaceuticals' outrageous Daraprim price-hike. Those in charge of the compounding pharmacy mentioned above were charged with homicide, but when a meningitis outbreak killed 11 children in an illegal Nigerian drug trial conducted by Pfizer, no one at Pfizer was charged with a crime. For more along these lines, see concise summaries of deeply revealing news articles about big pharma corruption.
No industry has aligned itself more closely with the breast cancer movement than the cosmetics industry. Yet while they prominently claim to care about women with breast cancer, their pink ribbon products all too often actually increase risk of the disease. Look Good Feel Better is a ... program run by the Personal Care Products Council (PCPC), the largest national trade group for the cosmetics industry, and the American Cancer Society (ACS), the nation’s largest cancer charity. They hold free workshops that give beauty tips and complimentary makeup kits to women in cancer treatment. Member companies of the [PCPC] donate cosmetic products for the kits given to cancer patients. The American Cancer Society administers the program nationwide. Many of the Look Good Feel Better kits contain ... carcinogens and hormone disruptors. These chemicals ... increase breast cancer risk, [and] interfere with breast cancer treatment. Most breast cancers are hormone-driven and common treatments target the body’s hormonal system. Some hormone disruptors – including methylparaben, which is in concealer and face wipes the ACS is giving to cancer patients – have been shown in a lab to interfere with Tamoxifen, a common hormonal breast cancer treatment. While the European Union has banned 1,300 chemicals from use in cosmetics, the United States has banned fewer than one dozen. The Personal Care Products Council spends millions of dollars lobbying against cosmetic safety regulations.
Note: Read about another example of egregious "pinkwashing" by a fracking company. And watch a promising new documentary on suppressed cancer cures. For more, see concise summaries of deeply revealing corporate corruption news articles, or learn about the promising cancer research too often suppressed in mainstream media.
Law firms around the United States are lining up plaintiffs for what they say could be "mass tort" actions against agrichemical giant Monsanto Co that claim the company's Roundup herbicide has caused cancer in farm workers and others exposed to the chemical. The latest lawsuit was filed Wednesday in Delaware. The lawsuit is similar to others filed last month in New York and California accusing Monsanto of long knowing that the main ingredient in Roundup, glyphosate, was hazardous. Monsanto "led a prolonged campaign of misinformation to convince government agencies, farmers and the general population that Roundup was safe," the lawsuit states. The litigation follows the World Health Organization's declaration in March that there was sufficient evidence to classify glyphosate as "probably carcinogenic to humans." "We can prove that Monsanto knew about the dangers of glyphosate," said Michael McDivitt, whose Colorado-based law firm is putting together cases for 50 individuals. Roundup ... brought Monsanto $4.8 billion in revenue in its fiscal 2015. But questions about Roundup's safety have dogged the company for years. Attorneys who have filed or are eying litigation cited strong evidence that links glyphosate to non-Hodgkin lymphoma. Monsanto is also fending off claims over its past manufacturing of polychlorinated biphenyls (PCBs), which the WHO classifies as known carcinogens. At least 700 lawsuits against Monsanto or Monsanto-related entities are pending.
Note: It's interesting to note that a Google search shows almost no major media picked up this key news. Read how the EPA used industry studies while ignoring independent studies to declare Roundup safe. Read also an excellent mercola.com article titled "GMO cookie is crumbling." Monsanto is trying to stop the state of California from listing Glyphosate as carcinogenic. For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.
New England Patriots quarterback Tom Brady is taking on an unlikely opponent: junk food. Brady got heated during an interview on Boston sports radio station WEEI about Coca-Cola. "The fact that they can sell that, you know, to kids, that's, I mean that's poison for kids, but they keep doing it," Brady said. Brady, a father to two sons and one daughter, also took a shot at breakfast cereals, specifically the cereal represented in advertisements by the character Tony the Tiger. "That's just America and that's what we've been conditioned to so, you know, we believe that Frosted Flakes are actually, is a food," he said. The 38-year-old, four-time Super Bowl champion credited a healthy diet as a big part of his on-field success. He also accused certain large food and beverage companies of false advertising. "All those companies make lots of money selling those things," Brady told WEEI. "They have lots of money to advertise, you know? When you go to the Super Bowl, it's you know, that's who are the sponsors. That's the education that we get. That's what we get brainwashed to believe."
Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.
Quebec-based Valeant Pharmaceutical's price hikes of drugs long off patent has raised the ire of U.S. legislators and frustrated Canadian physicians. Democrats on the House of Representatives committee on oversight and government reform sent a letter Monday to the committee's Republican chairman seeking a subpoena that would force Valeant to turn over documents tied to the U.S. price hikes of two heart drugs. In the U.S., the price of Isuprel or Isoprenaline increased 2,500 per cent and Nitropress went up 1,700 per cent in three years, as the drug changed hands. Valeant purchased the rights to both heart drugs from Marathon Pharmaceuticals in February. As huge overnight drug price hikes becomes an election issue in the U.S., some doctors in Canada struggle to get other prices rolled back. In late 2013, Valeant Canada announced that as of January 2014, the price of a one-month supply of Syprine would match the U.S. price of roughly $13,244, or about 13 times higher than the previous price. The medication makes the difference between a full and productive life or a downward course of increasing liver and neurological disease. For physicians, the price increase put them in the position of having to tell patients their disease can be managed or cured but at an out-of-pocket price of $200,000 a year for the rest of their lives.
Note: For more along these lines, see concise summaries of deeply revealing news articles about big pharma profiteering from reliable major media sources.
Until this week most of us had never heard of Daraprim, a drug that fights toxoplasmosis. But after the decision of the drug’s new owner, Turing Pharmaceuticals, to boost its cost per pill from $13.50 to a whopping $750, we’re all unlikely to forget its name or the name of Turing’s owner, 32-year-old Martin Shkreli. The outrage over the astronomical hike in a life-saving drug has opened the doors to a ... debate about the soaring costs of prescription medications in the United States. Daraprim ... has been around since the 1940s. Logic suggests that drugs that have been around for a while should decline in price. It turns out that isn’t the case. The profit-minded individual or company snaps up the patents, suddenly hikes the drug’s price and puts consumers – from insurance companies to individuals – in a position of either paying what is demanded or going without. Late this summer, Rodelis Therapeutics boosted the cost of 30 tablets of cycloserine, a tuberculosis drug, from $500 to $10,800. Early in the year, Valeant Pharmaceuticals International Inc boosted the prices of two heart drugs, Nitropress and Isuprel, by 525% and 212% on the same day that they acquired them. “Our duty is to shareholders and to maximize the value” of Valeant’s products, a company spokeswoman told the Wall Street Journal at the time.
Note: For more along these lines, see concise summaries of deeply revealing news articles about big pharma profiteering from reliable major media sources.
The U.S. government secretly allowed radiation from a damaged reactor to be released into air over the San Fernando and Simi valleys in the wake of a major nuclear meltdown in Southern California more than 50 years ago — fallout that nearby residents contend continues to cause serious health consequences and, in some cases, death. "Area Four," which is part of the once-secret Santa Susana Field Lab, [was] founded in 1947 to test experimental nuclear reactors and rocket systems. In 1959, Area Four was the site of one of the worst nuclear accidents in U.S. history. But the federal government still hasn't told the public that radiation was released into the atmosphere as a result of the partial nuclear meltdown. Now, whistleblowers ... have recounted how during and after that accident they were ordered to release dangerous radioactive gases into the air above Los Angeles and Ventura counties, often under cover of night, and how their bosses swore them to secrecy. For years starting in 1959, workers at Area Four were routinely instructed to release radioactive materials into the air above neighboring communities, through the exhaust stacks of nuclear reactors, open doors, and by burning radioactive waste. Radioactive contamination ... remains in the soil and water of Area Four and in some areas off-site. The fallout could be linked to illnesses, including cancer, among residents living nearby. In addition to the radiation, dozens of toxic chemicals, including TCE and Perchlorate, were also released ... from the 1950s to 80s.
Note: The government is lying, and people are dying. For lots more on this huge nuclear cover-up, see this NBC article and this one. You can also watch an eight-minute History Channel video on this disaster. The video states that the amount of radiation released during this accident was 240 times the amount released at Three Mile Island, making it one of the worst nuclear disasters in history, yet it was all kept secret. For more, see concise summaries of deeply revealing news articles on government corruption and nuclear power issues.
Testimony at a Senate hearing Tuesday demonstrated that [the Department of Veterans Affairs (VA)] remains a dangerous place for whistleblowers who report wrong doing. “The VA has a culture problem with whistleblower retaliation,” said Sen. Ron Johnson (R-Wis.), chairman of the Homeland Security and Governmental Affairs Committee. The “culture of fear” Johnson spoke of is evident in the number of VA cases handled by the Office of Special Counsel (OSC), an independent body that deals with whistleblower retaliation among other things. VA whistleblower reprisal cases received by OSC has been rising quickly, from 405 in fiscal 2013 to a projected 712 for fiscal 2015 – a 75 percent jump. [Special Counsel Carolyn] Lerner expects approximately 35 percent of the possible 4,000 prohibited personnel practice cases filed from across government this year to be from VA employees. Lerner complained to Obama in a Sept. 17 letter about the lack of discipline for VA managers found to have done wrong. After listing cases where managers were not disciplined, or only lightly so, for infractions, Lerner wrote: “The lack of accountability in these cases stands in stark contrast to disciplinary actions taken against VA whistleblowers. The VA has attempted to fire or suspend whistleblowers for minor indiscretions and, often, for activity directly related to the employee’s whistleblowing.”
Note: In 2011, BBC began asking if the U.S. government was "at war with whistleblowers". Watch a fascinating interview with whistleblower Rebekah Roth, an airline attendant who uncovers an abundance of key new information on 9/11. For more along these lines, see concise summaries of deeply revealing government corruption news articles from reliable major media sources.
Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.